James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $569.61 ($5.7M) on 2026-04-13, disclosed to the SEC on 2026-04-14.
Scheduled sale ($5.7M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $569.61 | 40 | $23K | 0.4% |
| 2 | $571.14 | 281 | $160K | 2.8% |
| 3 | $571.76 | 1,154 | $660K | 11.5% |
| 4 | $572.96 | 1,210 | $693K | 12.1% |
| 5 | $574.00 | 1,860 | $1.1M | 18.6% |
| 6 | $575.06 | 1,457 |
| $838K |
| 14.6% |
| 7 | $575.96 | 1,354 | $780K | 13.6% |
| 8 | $577.01 | 1,603 | $925K | 16.1% |
| 9 | $577.93 | 601 | $347K | 6.0% |
| 10 | $579.04 | 400 | $232K | 4.0% |
| 11 | $580.03 | 40 | $23K | 0.4% |
| Total | $574.88 avg | 10,000 | $5.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |